History of Helixio

Helixio: qpcr and rna seq. Microarray analysis

2014:
Hybrigenics launches Helixio, a new brand of genomic services provider
Helixio acquires the NextSeq 500
2013:
Hybrigenics acquires the genomic activities of Imaxio
2010:
Acquisition of an Illumina® Genome Analyser IIX and up-grade of the bioinformatics capacities
2009:
Acquisition of a high-throughput Illumina® i-Scan genotyping platform and installation in a new dedicated laboratory
2009:
Acquisition of an Applied Biosystems® 7900 HT Fast-Real-Time PCR system
2008:
Contribution to the BIOSPAN FUI program (French Public Funds for Innovative Research Program) involving Pierre Fabre and the INSERM research Unit U563
2007:
Imaxio becomes an Agilent Certified Service Provider
2006:
Acquisition of an Agilent Technologies® microarray platform
2006:
Diagnogene brings its genomic expertise to the merger with Avidis to form Imaxio
2000-2006:
Development of microarray technologies (cDNA probes) and contribution to several oncology research programs (Breast Med Consortium)
2000:
Creation of Diagnogene in Clermont-Ferrand and acquisition of the first microarray platform